Who is sponsoring NCT04581993?

NCT04581993 is sponsored by Aga Khan University.

What drugs are being tested in NCT04581993?

Interventions in NCT04581993: Super Cereal - wheat soya blend with sugar, Lipid-based nutrient supplement-medium quantity (LNS-MQ), Social and behavior change communication (SBCC).

What condition does NCT04581993 study?

NCT04581993 studies Stunting, Malnutrition, Child.

Is NCT04581993 still recruiting?

NCT04581993 is currently completed. Last updated 16 August 2023.

Last reviewed 2023-08-16 · How we verify

NCT04581993

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of SNF and SBCC to Prevent Stunting Among Children in Afghanistan: a Quasi-experimental Study

Completed NA Last updated 16 August 2023

What this trial tests

NA trial testing Super Cereal - wheat soya blend with sugar in Stunting in 33,100 participants. Completed in 31 December 2022.

Timeline

1 February 2021

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Aga Khan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	factorial
Masking	single
Primary purpose	prevention
Enrollment	33,100
Start date	1 February 2021
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Afghanistan

Drugs / interventions tested

Super Cereal - wheat soya blend with sugar
Lipid-based nutrient supplement-medium quantity (LNS-MQ)
Social and behavior change communication (SBCC)

Conditions studied

Stunting — all drugs for Stunting →
Malnutrition, Child — all drugs for Malnutrition, Child →

Sponsor

Aga Khan University

Who can join

Adults 6 Months to 49, any sex, with Stunting or Malnutrition, Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Over the years, there has been some progress made in reducing stunting in Afghanistan, the prevalence remains high with half of the provinces experiencing rates above the WHO alert threshold. As part of the Country Strategic Plan (CSP), the World Food Programme (WFP) plans to implement a stunting prevention programme in collaboration with Ministry of Public Health (MoPH) through its Public Nutrition Department (PND) in selected locations with stunting rates above 45%. The programme will emphasis on appropriate nutrition support in the '1000 days' window of opportunity with special focus on proven effective nutrition interventions such appropriate breast feeding, complementary feeding, micronutrient supplementation, malnutrition treatment and prevention, WASH.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Specialized nutritious foods and behavior change communication interventions during the first 1000 d of life to prevent stunting: a quasi-experimental study in Afghanistan.
Soofi SB, Khan GN, Sajid M, Hussainyar MA, et al · · 2024 · cited 4× · PMID 39004283 · DOI 10.1016/j.ajcnut.2024.07.007
Effectiveness of Specialized Nutritious Foods and Social and Behavior Change Communication Interventions to Prevent Stunting among Children in Badakhshan, Afghanistan: Protocol for a Quasi-Experimental Study.
Soofi SB, Khan GN, Ariff S, Rizvi A, et al · · 2021 · cited 1× · PMID 34449665 · DOI 10.3390/mps4030055

Verify or expand the search:

Other recruiting trials for Stunting

Currently open trials in the same condition.

NCT07207434 — Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan · Phase 2 · recruiting
NCT07037498 — Effect of Moringa Royal Jelly on the Nutritional Status and Cognitive Level of Adolescent Girls · NA · active not recruiting
NCT06362837 — Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services · NA · recruiting
NCT05793294 — Child Health, Nutrition and Microbiome Development · active not recruiting
NCT06018636 — Impact of Diet and Nutrition on Growth and Development in Young Children · recruiting

Other Aga Khan University trials

Trials by the same sponsor.

NCT07475793 — Image Guided Genicular Nerve Radiofrequency Ablation for Chronic Knee Osteoarthritis · NA · not yet recruiting
NCT07197684 — Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surg · NA · not yet recruiting
NCT07356063 — Self-Efficacy Enhancement Using a Multicomponent Support Group for Caregivers of Children With DMD/SMA · NA · not yet recruiting
NCT07451951 — Effectiveness of SQLNS vs MQLNS for Prevention of Undernutrition in Children 6-12 Months · NA · not yet recruiting
NCT07357350 — Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04581993 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aga Khan University
Last refreshed: 16 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04581993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing